Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALITNYSE:DXCNYSE:EEXNYSE:EVH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALITAlight$5.98+0.9%$5.47$4.49▼$8.93$3.22B16.59 million shs4.97 million shsDXCDXC Technology$16.24+1.8%$15.49$13.44▼$24.83$2.94B1.21.49 million shs1.68 million shsEEXEmerald$5.30+4.1%$4.65$3.22▼$6.65$1.05B1.09170,994 shs45,037 shsEVHEvolent Health$11.79+0.5%$9.18$7.06▼$33.63$1.38B1.012.52 million shs1.47 million shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALITAlight+0.93%+6.03%+9.94%+25.39%-15.85%DXCDXC Technology+1.82%+6.67%+7.84%+9.04%-10.72%EEXEmerald+4.04%+7.94%+13.13%+45.05%-4.50%EVHEvolent Health+0.68%+9.83%+37.73%+18.14%-40.27%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALITAlight4.4751 of 5 stars3.44.01.70.02.33.32.5DXCDXC Technology3.3966 of 5 stars1.93.00.02.01.81.71.9EEXEmerald1.9036 of 5 stars3.53.00.80.01.30.00.0EVHEvolent Health1.768 of 5 stars3.53.00.00.01.70.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALITAlight 2.86Moderate Buy$9.8664.97% UpsideDXCDXC Technology 1.83Reduce$17.004.68% UpsideEEXEmerald 3.00Buy$7.9049.06% UpsideEVHEvolent Health 3.00Buy$17.7950.85% UpsideCurrent Analyst Ratings BreakdownLatest EEX, ALIT, DXC, and EVH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/20/2025ALITAlightNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$8.006/20/2025EVHEvolent HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$13.005/21/2025DXCDXC TechnologyJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$22.00 ➝ $18.005/15/2025DXCDXC TechnologyRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$27.00 ➝ $18.005/15/2025DXCDXC TechnologyMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$22.00 ➝ $16.005/15/2025DXCDXC TechnologyBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$26.00 ➝ $17.005/13/2025EVHEvolent HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.005/12/2025DXCDXC TechnologyGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral5/9/2025ALITAlightWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$11.00 ➝ $9.005/9/2025EVHEvolent HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$14.00 ➝ $15.005/2/2025EEXEmeraldRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$7.80 ➝ $7.80(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALITAlight$2.33B1.38$1.10 per share5.41$7.95 per share0.75DXCDXC Technology$12.87B0.23$10.97 per share1.48$19.28 per share0.84EEXEmerald$398.80M2.64$0.22 per share24.54$1.90 per share2.79EVHEvolent Health$2.55B0.54$1.53 per share7.73$8.70 per share1.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALITAlight-$157M-$0.14N/A9.05N/A-2.65%5.74%2.86%8/5/2025 (Estimated)DXCDXC Technology$389M$2.117.704.914.213.02%19.36%4.77%8/6/2025 (Estimated)EEXEmerald$2.20M$0.03176.73∞N/A1.57%1.75%0.63%8/6/2025 (Estimated)EVHEvolent Health-$61.62M-$1.23N/AN/AN/A-4.54%3.64%1.44%8/6/2025 (Estimated)Latest EEX, ALIT, DXC, and EVH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q4 2025DXCDXC Technology$0.76$0.84+$0.08$1.42$3.13 billion$3.17 billion5/8/2025Q1 2025ALITAlight$0.12$0.10-$0.02-$0.05$542.66 million$548.00 million5/8/2025Q1 2025EVHEvolent Health$0.08$0.06-$0.02-$0.63$460.15 million$483.65 million5/1/2025Q1 2025EEXEmerald$0.07$0.08+$0.01$0.08$134.30 million$147.70 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALITAlight$0.162.68%N/AN/A N/ADXCDXC TechnologyN/AN/AN/AN/AN/AEEXEmerald$0.061.13%N/A200.00%N/AEVHEvolent HealthN/AN/AN/AN/AN/ALatest EEX, ALIT, DXC, and EVH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/30/2025ALITAlightquarterly$0.043.13%6/2/20256/2/20256/16/20255/2/2025EEXEmeraldquarterly$0.01501.3%5/12/20255/12/20255/22/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALITAlight0.471.181.18DXCDXC Technology0.861.221.22EEXEmerald1.281.591.59EVHEvolent Health0.690.980.98Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALITAlight96.74%DXCDXC Technology96.20%EEXEmerald14.90%EVHEvolent HealthN/AInsider OwnershipCompanyInsider OwnershipALITAlight1.93%DXCDXC Technology0.61%EEXEmerald4.00%EVHEvolent Health1.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALITAlight9,500538.26 million527.87 millionOptionableDXCDXC Technology120,000181.27 million180.16 millionOptionableEEXEmerald600198.86 million190.91 millionOptionableEVHEvolent Health4,500117.40 million115.76 millionOptionableEEX, ALIT, DXC, and EVH HeadlinesRecent News About These CompaniesEvolent Health (NYSE:EVH) Shares Gap Down - Here's WhyJuly 2 at 12:18 PM | marketbeat.com3 Reasons to Avoid EVH and 1 Stock to Buy InsteadJune 30, 2025 | msn.comUBS Views Evolent Health’s Q2 Outlook And Financing Moves As ‘Incrementally Positive’June 23, 2025 | msn.comEvolent Health (NYSE:EVH) Trading 5.4% Higher - Here's What HappenedJune 23, 2025 | marketbeat.comEvolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar?June 23, 2025 | zacks.comEvolent Health, Inc.: Evolent reiterates Q2 and full year guidance for Adjusted EBITDAJune 20, 2025 | finanznachrichten.deJMP Securities Reaffirms Market Outperform Rating for Evolent Health (NYSE:EVH)June 20, 2025 | marketbeat.comEvolent reiterates Q2 and full year guidance for Adjusted EBITDAJune 20, 2025 | prnewswire.comEvolent Health, Inc (NYSE:EVH) Receives Consensus Rating of "Buy" from BrokeragesJune 19, 2025 | marketbeat.comEvolent Health (NYSE:EVH) Stock Price Up 5% - Here's What HappenedJune 17, 2025 | marketbeat.comEvolent Health (NYSE:EVH) Shares Down 3.1% - Time to Sell?June 16, 2025 | marketbeat.comSalem Investment Counselors Inc. Increases Stock Holdings in Evolent Health, Inc. (NYSE:EVH)June 13, 2025 | marketbeat.comEVH Q1 Earnings Call: Oncology Navigation Launch and AI Automation Drive Strategic FocusJune 10, 2025 | msn.comCongress Asset Management Co. Sells 36,382 Shares of Evolent Health, Inc. (NYSE:EVH)June 9, 2025 | marketbeat.comEvolent Health (NYSE:EVH) Shares Up 8.1% - What's Next?June 4, 2025 | marketbeat.comEvolent Health’s SWOT analysis: value-based care provider faces challenges, opportunitiesMay 27, 2025 | investing.comReflecting On Healthcare Technology for Providers Stocks’ Q1 Earnings: Evolent Health (NYSE:EVH)May 23, 2025 | msn.comWhy Evolent Health, Inc.’s (EVH) Stock Is Down 13.27%May 10, 2025 | aaii.comAExpert Outlook: Evolent Health Through The Eyes Of 9 AnalystsMay 9, 2025 | benzinga.comEvolent Health, Inc. (EVH) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comEvolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to SayMay 9, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseThese 3 Dividend Stocks Pay You to Stay Calm in SummerBy Chris Markoch | June 9, 2025View These 3 Dividend Stocks Pay You to Stay Calm in SummerSarepta Drops 42% on Fatalities; Markets Eye Solid BiosciencesBy Leo Miller | June 18, 2025View Sarepta Drops 42% on Fatalities; Markets Eye Solid BiosciencesEEX, ALIT, DXC, and EVH Company DescriptionsAlight NYSE:ALIT$5.98 +0.06 (+0.93%) Closing price 07/3/2025 03:55 PM EasternExtended Trading$5.98 +0.01 (+0.17%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Alight, Inc. provides cloud-based integrated digital human capital and business solutions worldwide. The company operates through two segments, Employer Solutions and Professional Services. The Employer Solutions segment offers employee wellbeing, integrated benefits administration, healthcare navigation, financial wellbeing, leave of absence management, retiree healthcare and payroll; and operates AI-led capabilities software. The Professional Services segment offers consulting offerings, such as cloud advisory, deployment, and optimization services for cloud platforms. The company provides Alight Worklife, an intuitive, cloud-based employee engagement platform. Its solutions enable employees to enrich their health, wealth, and wellbeing that helps organizations achieve a high-performance culture. Alight, Inc. was founded in 2020 and is based in Lincolnshire, Illinois.DXC Technology NYSE:DXC$16.24 +0.28 (+1.75%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$16.20 -0.04 (-0.25%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DXC Technology Company, together with its subsidiaries, provides information technology services and solutions in the United States, the United Kingdom, rest of Europe, Australia, and internationally. It operates in two segments, Global Business Services (GBS) and Global Infrastructure Services (GIS). The GBS segment offers a portfolio of analytics services and extensive partner ecosystem that help its customers to gain insights, automate operations, and accelerate their transformation journeys; and software engineering, consulting, and data analytics solutions, which enable businesses to run and manage their mission-critical functions, transform their operations, and develop new ways of doing business. This segment also simplifies, modernize, and accelerate mission-critical applications that support business agility and growth through applications services; provides proprietary modular insurance software and platforms; and operates a wide spectrum of insurance business process services, as well as helps to operate and improve bank cards, payment and lending process and operations, and customer experiences. The GIS segment offers security services, such as IT security, operations and culture for migrating to the cloud, protecting data with a zero-trust strategy, and manage a security operation center; and cloud infrastructure and IT outsourcing services. This segment also delivers a consumer-like experience, centralize IT management, and support services, as well as improves the total cost of ownership; and orchestrates hybrid cloud and multicloud environments. The company markets and sells its products through direct sales force to commercial businesses and public sector enterprises. DXC Technology Company was founded in 1959 and is headquartered in Ashburn, Virginia.Emerald NYSE:EEX$5.30 +0.21 (+4.13%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$5.41 +0.11 (+2.08%) As of 07/3/2025 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Emerald Holding, Inc. operates business-to-business (B2B) trade shows in the United States. The company provides B2B trade show franchises; and B2B print publications and digital media products, which provide industry specific business news and information across various sectors. It also offers B2B e-commerce and digital merchandising solutions to manufacturers and retailers through Elastic Suite and Bulletin platforms. The company serves retail, design, technology, equipment, and safety and security. Emerald Holding, Inc. was incorporated in 2013 and is headquartered in New York, New York.Evolent Health NYSE:EVH$11.79 +0.06 (+0.51%) As of 07/3/2025 03:30 PM EasternEvolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
